menu
    • menu

    Company profile for Galectin Therapeutics

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics lev...
    Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost-effective and efficient development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Galectin TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4960 Peachtree Industrial Boulevard Suite 240 Norcross, 30071
    Telephone
    Telephone
    678-620-3186
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://galectintherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/galectin-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/galectingalt

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PCHi

    PCHi

    Not Confirmed

    envelop Contact Supplier

    PCHi

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Galectin Therapeutics Appoints Henry Brem to Board of Directors
    Galectin Therapeutics Appoints Henry Brem to Board of Directors

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257084/27423/en/Galectin-Therapeutics-Strengthens-Board-of-Directors-with-Appointment-of-Henry-Brem-M-D.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Galectin Hosts Virtual KOL Event On Belapectin Development
    Galectin Hosts Virtual KOL Event On Belapectin Development

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3246082/27423/en/Galectin-Therapeutics-to-Host-Virtual-KOL-Event-to-Discuss-Belapectin-Development-Program-for-Treatment-of-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-Cirrhosis-and-Porta.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    Galectin Therapeutics Updates FDA Response, Secures $10M Credit
    Galectin Therapeutics Updates FDA Response, Secures $10M Credit

    19 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/19/3208448/27423/en/Galectin-Therapeutics-Provides-Regulatory-Update-Following-FDA-Written-Response-and-Announces-an-Additional-10-Million-Line-of-Credit-from-Richard-E-Uihlein-Sufficient-to-Cover-Exp.html

    GLOBENEWSWIRE
    19 Dec 2025
    Share Share
    Galectin Reports Quarter Financial Results & Business
    Galectin Reports Quarter Financial Results & Business

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188253/27423/en/Galectin-Therapeutics-Reports-Financial-Results-for-the-quarter-ended-September-30-2025-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Galectin Therapeutics to Present NAVIGATE Results at AASLD 2025
    Galectin Therapeutics to Present NAVIGATE Results at AASLD 2025

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184519/27423/en/Galectin-Therapeutics-Presented-NAVIGATE-Trial-Results-at-the-American-Association-for-the-Study-of-Liver-Diseases-AASLD-2025-Annual-Meeting.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Galectin Therapeutics To Present At H.C. Wainwright Investor
    Galectin Therapeutics To Present At H.C. Wainwright Investor

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169313/27423/en/Galectin-Therapeutics-to-Present-at-the-H-C-Wainwright-9th-Annual-MASH-Investor-Conference.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search